Alzheimer's disease (AD) is characterized by amyloid-β plaques and tau aggregates, with autophagy dysfunction playing a key pathogenic role. While autophagy modulation shows therapeutic promise, comprehensive bibliometric analyses are lacking.
Objective
This study aims to map the research landscape of autophagy in AD through bibliometric analysis, identifying key trends, contributors, and emerging focus areas.
Methods
We analyzed 4018 publications (2003–2023) from Web of Science using VOSviewer and CiteSpace. Publication trends, influential authors, countries, institutions, and research hotspots were examined through co-occurrence, burst detection, and clustering analyses.
Results
Annual publications have steadily increased, peaking in 2022. The US led in output and citations, with major contributions from the University of California and New York University. Ralph A. Nixon emerged as the most influential author. Early research (2003–2013) primarily focused on protein degradation mechanisms, whereas recent studies (2014–2023) emphasize mitochondrial dysfunction, apoptosis, and related pathways. Key evolving topics include endoplasmic reticulum stress and chaperone-mediated autophagy, with significant implications for therapeutic innovation.
Conclusions
Autophagy plays a critical role in AD pathogenesis and represents a promising therapeutic target. Despite mechanistic advances, clinical translation remains challenging. Future research should prioritize multi-omics integration, drug delivery optimization, and managing risks associated with excessive autophagy activation. These findings provide valuable insights for developing novel AD therapies targeting autophagy.
ZhangXWZhuXXTangDS, et al.Targeting autophagy in Alzheimer's disease: animal models and mechanisms. Zool Res2023; 44: 1132–1145.
2.
Tahami MonfaredAAByrnesMJWhiteLA, et al.Alzheimer's disease: epidemiology and clinical progression. Neurol Ther2022; 11: 553–569.
3.
AberathneIKulasiriDSamarasingheS. Detection of Alzheimer's disease onset using MRI and PET neuroimaging: longitudinal data analysis and machine learning. Neural Regen Res2023; 18: 2134–2140.
4.
GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health2022; 7: e105–e125.
5.
TiwariSAtluriVKaushikA, et al.Alzheimer's disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine2019; 14: 5541–5554.
6.
UddinMSStachowiakAMamunAA, et al.Autophagy and Alzheimer's disease: from molecular mechanisms to therapeutic implications. Front Aging Neurosci2018; 10: 4.
7.
PettiUBakerSKorhonenA. A systematic literature review of automatic Alzheimer's disease detection from speech and language. J Am Med Inform Assoc2020; 27: 1784–1797.
8.
LuGWangYShiY, et al.Autophagy in health and disease: from molecular mechanisms to therapeutic target. MedComm2022; 3: e150.
9.
TakeshigeKBabaMTsuboiS, et al.Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction. J Cell Biol1992; 119: 301–311.
10.
TsukadaMOhsumiY. Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett1993; 333: 169–174.
11.
ShengRQinZH. History and current status of autophagy research. Adv Exp Med Biol2019; 1206: 3–37.
12.
NieTZhuLYangQ. The classification and basic processes of autophagy. Adv Exp Med Biol2021; 1208: 3–16.
13.
FarréJCSubramaniS. Mechanistic insights into selective autophagy pathways: lessons from yeast. Nat Rev Mol Cell Biol2016; 17: 537–552.
ChenWZhaoHLiY. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduct Target Ther2023; 8: 333.
16.
BolandBKumarALeeS, et al.Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J Neurosci2008; 28: 6926–6937.
17.
NixonRAYangDS. Autophagy failure in Alzheimer's disease–locating the primary defect. Neurobiol Dis2011; 43: 38–45.
LiLZhangXLeW. Autophagy dysfunction in Alzheimer's disease. Neurodegener Dis2010; 7: 265–271.
20.
KouXChenN. Resveratrol as a natural autophagy regulator for prevention and treatment of Alzheimer's disease. Nutrients2017; 9: 927.
21.
LeeJHYangDSGoulbourneCN, et al.Faulty autolysosome acidification in Alzheimer's disease mouse models induces autophagic build-up of Aβ in neurons, yielding senile plaques. Nat Neurosci2022; 25: 688–701.
22.
LeiYKlionskyDJ. Transcriptional regulation of autophagy and its implications in human disease. Cell Death Differ2023; 30: 1416–1429.
23.
NinkovAFrankJRMaggioLA. Bibliometrics: methods for studying academic publishing. Perspect Med Educ2022; 11: 173–176.
24.
ChenCM. CiteSpaceII: detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Technol2006; 57: 359–377.
25.
Van EckNJWaltmanL. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics2010; 84: 523–538.
26.
NixonRA. The role of autophagy in neurodegenerative disease. Nat Med2013; 19: 983–997.
27.
NixonRAWegielJKumarA, et al.Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol2005; 64: 113–122.
28.
ChoiAMRyterSWLevineB. Autophagy in human health and disease. N Engl J Med2013; 368: 651–662.
29.
OrrMEOddoS. Autophagic/lysosomal dysfunction in Alzheimer's disease. Alzheimers Res Ther2013; 5: 53.
30.
LiYLiSWuH. Ubiquitination-proteasome system (UPS) and autophagy two main protein degradation machineries in response to cell stress. Cells2022; 11: 851.
31.
HanZTianRRenP, et al. Parkinson's disease and Alzheimer's disease: a Mendelian randomization study. BMC Med Genet2018; 19(Suppl 1): 215.
32.
FestaBPBarbosaADRobM, et al.The pleiotropic roles of autophagy in Alzheimer's disease: from pathophysiology to therapy. Curr Opin Pharmacol2021; 60: 149–157.
33.
LiQLiuYSunM. Autophagy and Alzheimer’s disease. Cell Mol Neurobiol2017; 37: 377–388.
34.
Sanchez-VaroRMejias-OrtegaMFernandez-ValenzuelaJJ, et al. Transgenic mouse models of Alzheimer's disease: an integrative analysis. Int J Mol Sci2022; 23: 5404.
35.
Abd-ElrahmanKSHamiltonAVasefiM, et al.Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer's disease mouse models. Mol Brain2018; 11: 19.
36.
CaiCZZhuangXXZhuQ, et al.Enhancing autophagy maturation with CCZ1-MON1A complex alleviates neuropathology and memory defects in Alzheimer disease models. Theranostics2022; 12: 1738–1755.
37.
CenXChenYXuX, et al. Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer's disease mouse model. Nat Commun2020; 11: 5731.
38.
De la CuevaMAntequeraDOrdoñez-GutierrezL, et al.Amyloid-β impairs mitochondrial dynamics and autophagy in Alzheimer's disease experimental models. Sci Rep2022; 12: 10092.
39.
WangQWangYLiS, et al.PACAP-Sirtuin3 alleviates cognitive impairment through autophagy in Alzheimer's disease. Alzheimers Res Ther2023; 15: 184.
40.
RamakrishanPRajangamJMahinoorSS, et al.Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer's disease in type 2 diabetes. Metab Brain Dis2025; 40: 132.
41.
Zare-ShahabadiAMasliahEJohnsonGV, et al.Autophagy in Alzheimer's disease. Rev Neurosci2015; 26: 385–395.
42.
KimJKunduMViolletB, et al.AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol2011; 13: 132–141.
43.
MengTLinSZhuangH, et al.Recent progress in the role of autophagy in neurological diseases. Cell Stress2019; 3: 141–161.
44.
LiuJLiL. Targeting autophagy for the treatment of Alzheimer's disease: challenges and opportunities. Front Mol Neurosci2019; 12: 203.
45.
LiYYQinZHShengR. The multiple roles of autophagy in neural function and diseases. Neurosci Bull2024; 40: 363–382.
46.
RashidHOYadavRKKimHR, et al.ER Stress: autophagy induction, inhibition and selection. Autophagy2015; 11: 1956–1977.
47.
WangYTLuJH. Chaperone-mediated autophagy in neurodegenerative diseases: molecular mechanisms and pharmacological opportunities. Cells2022; 11: 2250.
48.
WangGMaoZ. Chaperone-mediated autophagy: roles in neurodegeneration. Transl Neurodegener2014; 3: 20.
49.
TranMReddyPH. Defective autophagy and mitophagy in aging and Alzheimer's disease. Front Neurosci2021; 14: 612757.
50.
BourdenxMMartín-SeguraAScrivoA, et al.Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome. Cell2021; 184: 2696–2714.e25.
51.
HuangJWangJ. Selective protein degradation through chaperone mediated autophagy: implications for cellular homeostasis and disease (review). Mol Med Rep2025; 31: 13.
52.
ParkHKangJHLeeS. Autophagy in neurodegenerative diseases: a hunter for aggregates. Int J Mol Sci2020; 21: 3369.
53.
HeckmannBLTeubnerBJWTummersB, et al.LC3-associated Endocytosis facilitates β-amyloid clearance and mitigates neurodegeneration in murine Alzheimer's disease. Cell2019; 178: 536–551.e14.
54.
ZongYLiHLiaoP, et al.Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduct Target Ther2024; 9: 124.
55.
MisraniATabassumSYangL. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease. Front Aging Neurosci2021; 13: 617588.
56.
AlqahtaniTDeoreSLKideAA, et al.Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis – an updated review. Mitochondrion2023; 71: 83–92.
MoawadMHEDSeragIAlkhawaldehIM, et al. Exploring the mechanisms and therapeutic approaches of mitochondrial dysfunction in Alzheimer's disease: an educational literature review. Mol Neurobiol. Epub ahead of print 10 September 2024. DOI: https://doi.org/10.1007/s12035-024-04468-y.
59.
MaryAEysertFCheclerF, et al.Mitophagy in Alzheimer's disease: molecular defects and therapeutic approaches. Mol Psychiatry2023; 28: 202–216.
60.
RaiSNSinghCSinghA, et al.Mitochondrial dysfunction: a potential therapeutic target to treat Alzheimer's disease. Mol Neurobiol2020; 57: 3075–3088.
61.
DasSShuklaNSinghSS, et al.Mechanism of interaction between autophagy and apoptosis in cancer. Apoptosis2021; 26: 512–533.
62.
ZhangJZhangYWangJ, et al.Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther2024; 9: 211.
63.
KalraRSKandimallaRBkB. Editorial: apoptosis, autophagy, and mitophagy dysfunction in Alzheimer's disease: evolving emergence and mechanisms. Front Mol Neurosci2022; 15: 1049914.
